Atossa Therapeutics(ATOS) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2026 Atossa Therapeutics, Inc. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) Delaware 001-35610 26-4753208 (Commission File Number) (IRS Employer 1448 NW Market Street, Suite 500 Seattle, Washington 98107 (Address of Principal E ...